Intravenous (IV) paracetamol (Perfalgan ®) is an patients unable to tolerate the oral form when 'nil by mouth', vomiting or with no absorptive capacity. suggests that in comparison to the oral route it has superior pharmacokinetics 1 1-3 sparing ability (50% vs. oral 30%) 1,4. However, there is little information on the new IV paracetamol 5,6. The IV form's with greater potential for error, particularly in 5 particularly the risk of hepatotoxicity, as well as IV on their formulary. representatives. When a new formulary application is However, when the agent is more costly, has potential
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.